AirSculpt Technologies (AIRS) Competitors

AirSculpt Technologies logo
$0.65 -0.06 (-8.87%)
Closing price 04:00 PM Eastern
Extended Trading
$0.66 +0.00 (+0.57%)
As of 04:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AIRS vs. CCM, NIVF, HCA, THC, and EHC

Should you buy AirSculpt Technologies stock or one of its competitors? AirSculpt Technologies's main competitors and comparable companies include Concord Medical Services (CCM), NewGenIvf Group (NIVF), HCA Healthcare (HCA), Tenet Healthcare (THC), and Encompass Health (EHC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare facilities" industry.

How does AirSculpt Technologies compare to Concord Medical Services?

Concord Medical Services (NYSE:CCM) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

Concord Medical Services has a beta of -0.77, suggesting that its share price is 177% less volatile than the broader market. Comparatively, AirSculpt Technologies has a beta of 2.29, suggesting that its share price is 129% more volatile than the broader market.

AirSculpt Technologies has higher revenue and earnings than Concord Medical Services.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concord Medical Services$65.85M0.24-$13.27MN/AN/A
AirSculpt Technologies$147.68M0.33-$11.67M-$0.13N/A

91.5% of AirSculpt Technologies shares are held by institutional investors. 46.5% of Concord Medical Services shares are held by company insiders. Comparatively, 44.6% of AirSculpt Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

AirSculpt Technologies has a consensus target price of $2.75, suggesting a potential upside of 320.30%. Given AirSculpt Technologies' stronger consensus rating and higher probable upside, analysts plainly believe AirSculpt Technologies is more favorable than Concord Medical Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concord Medical Services
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
AirSculpt Technologies
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Concord Medical Services has a net margin of 0.00% compared to AirSculpt Technologies' net margin of -6.36%. Concord Medical Services' return on equity of 0.00% beat AirSculpt Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Concord Medical ServicesN/A N/A N/A
AirSculpt Technologies -6.36%-9.43%-4.94%

In the previous week, AirSculpt Technologies had 3 more articles in the media than Concord Medical Services. MarketBeat recorded 3 mentions for AirSculpt Technologies and 0 mentions for Concord Medical Services. AirSculpt Technologies' average media sentiment score of 0.63 beat Concord Medical Services' score of 0.00 indicating that AirSculpt Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Concord Medical Services Neutral
AirSculpt Technologies Positive

Summary

AirSculpt Technologies beats Concord Medical Services on 10 of the 14 factors compared between the two stocks.

How does AirSculpt Technologies compare to NewGenIvf Group?

AirSculpt Technologies (NASDAQ:AIRS) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, analyst recommendations, profitability and dividends.

91.5% of AirSculpt Technologies shares are held by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are held by institutional investors. 44.6% of AirSculpt Technologies shares are held by insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

AirSculpt Technologies presently has a consensus target price of $2.75, suggesting a potential upside of 320.30%. Given AirSculpt Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe AirSculpt Technologies is more favorable than NewGenIvf Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AirSculpt Technologies
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
NewGenIvf Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

NewGenIvf Group has lower revenue, but higher earnings than AirSculpt Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AirSculpt Technologies$147.68M0.33-$11.67M-$0.13N/A
NewGenIvf Group$4.73M0.01$9.88MN/AN/A

In the previous week, AirSculpt Technologies and AirSculpt Technologies both had 3 articles in the media. AirSculpt Technologies' average media sentiment score of 0.63 beat NewGenIvf Group's score of 0.44 indicating that AirSculpt Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AirSculpt Technologies
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
NewGenIvf Group
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

NewGenIvf Group has a net margin of 0.00% compared to AirSculpt Technologies' net margin of -6.36%. NewGenIvf Group's return on equity of 0.00% beat AirSculpt Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
AirSculpt Technologies-6.36% -9.43% -4.94%
NewGenIvf Group N/A N/A N/A

AirSculpt Technologies has a beta of 2.29, indicating that its share price is 129% more volatile than the broader market. Comparatively, NewGenIvf Group has a beta of 0.19, indicating that its share price is 81% less volatile than the broader market.

Summary

AirSculpt Technologies beats NewGenIvf Group on 9 of the 13 factors compared between the two stocks.

How does AirSculpt Technologies compare to HCA Healthcare?

HCA Healthcare (NYSE:HCA) and AirSculpt Technologies (NASDAQ:AIRS) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, media sentiment, valuation, analyst recommendations and profitability.

In the previous week, HCA Healthcare had 26 more articles in the media than AirSculpt Technologies. MarketBeat recorded 29 mentions for HCA Healthcare and 3 mentions for AirSculpt Technologies. AirSculpt Technologies' average media sentiment score of 0.63 beat HCA Healthcare's score of 0.47 indicating that AirSculpt Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HCA Healthcare
6 Very Positive mention(s)
4 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
AirSculpt Technologies
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

62.7% of HCA Healthcare shares are held by institutional investors. Comparatively, 91.5% of AirSculpt Technologies shares are held by institutional investors. 1.5% of HCA Healthcare shares are held by insiders. Comparatively, 44.6% of AirSculpt Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

HCA Healthcare has a net margin of 8.61% compared to AirSculpt Technologies' net margin of -6.36%. AirSculpt Technologies' return on equity of -9.43% beat HCA Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
HCA Healthcare8.61% -198.52% 10.81%
AirSculpt Technologies -6.36%-9.43%-4.94%

HCA Healthcare has higher revenue and earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than HCA Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HCA Healthcare$78.70B1.22$6.78B$30.1815.26
AirSculpt Technologies$147.68M0.33-$11.67M-$0.13N/A

HCA Healthcare currently has a consensus target price of $482.30, indicating a potential upside of 4.72%. AirSculpt Technologies has a consensus target price of $2.75, indicating a potential upside of 320.30%. Given AirSculpt Technologies' higher possible upside, analysts clearly believe AirSculpt Technologies is more favorable than HCA Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HCA Healthcare
1 Sell rating(s)
7 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.63
AirSculpt Technologies
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

HCA Healthcare has a beta of 1.11, suggesting that its stock price is 11% more volatile than the broader market. Comparatively, AirSculpt Technologies has a beta of 2.29, suggesting that its stock price is 129% more volatile than the broader market.

Summary

HCA Healthcare beats AirSculpt Technologies on 10 of the 16 factors compared between the two stocks.

How does AirSculpt Technologies compare to Tenet Healthcare?

AirSculpt Technologies (NASDAQ:AIRS) and Tenet Healthcare (NYSE:THC) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

AirSculpt Technologies presently has a consensus target price of $2.75, suggesting a potential upside of 320.30%. Tenet Healthcare has a consensus target price of $296.65, suggesting a potential upside of 12.71%. Given AirSculpt Technologies' higher probable upside, equities analysts plainly believe AirSculpt Technologies is more favorable than Tenet Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AirSculpt Technologies
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Tenet Healthcare
0 Sell rating(s)
3 Hold rating(s)
19 Buy rating(s)
0 Strong Buy rating(s)
2.86

AirSculpt Technologies has a beta of 2.29, meaning that its share price is 129% more volatile than the broader market. Comparatively, Tenet Healthcare has a beta of 1.2, meaning that its share price is 20% more volatile than the broader market.

91.5% of AirSculpt Technologies shares are owned by institutional investors. Comparatively, 95.4% of Tenet Healthcare shares are owned by institutional investors. 44.6% of AirSculpt Technologies shares are owned by insiders. Comparatively, 1.0% of Tenet Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Tenet Healthcare had 3 more articles in the media than AirSculpt Technologies. MarketBeat recorded 6 mentions for Tenet Healthcare and 3 mentions for AirSculpt Technologies. Tenet Healthcare's average media sentiment score of 0.86 beat AirSculpt Technologies' score of 0.63 indicating that Tenet Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AirSculpt Technologies
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Tenet Healthcare
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tenet Healthcare has higher revenue and earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Tenet Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AirSculpt Technologies$147.68M0.33-$11.67M-$0.13N/A
Tenet Healthcare$23.63B0.89$1.41B$34.487.63

Tenet Healthcare has a net margin of 13.09% compared to AirSculpt Technologies' net margin of -6.36%. Tenet Healthcare's return on equity of 28.22% beat AirSculpt Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
AirSculpt Technologies-6.36% -9.43% -4.94%
Tenet Healthcare 13.09%28.22%6.12%

Summary

Tenet Healthcare beats AirSculpt Technologies on 13 of the 16 factors compared between the two stocks.

How does AirSculpt Technologies compare to Encompass Health?

AirSculpt Technologies (NASDAQ:AIRS) and Encompass Health (NYSE:EHC) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and risk.

AirSculpt Technologies currently has a consensus price target of $2.75, suggesting a potential upside of 320.30%. Encompass Health has a consensus price target of $154.25, suggesting a potential upside of 16.81%. Given AirSculpt Technologies' higher possible upside, analysts plainly believe AirSculpt Technologies is more favorable than Encompass Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AirSculpt Technologies
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Encompass Health
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14

Encompass Health has a net margin of 10.17% compared to AirSculpt Technologies' net margin of -6.36%. Encompass Health's return on equity of 18.35% beat AirSculpt Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
AirSculpt Technologies-6.36% -9.43% -4.94%
Encompass Health 10.17%18.35%8.38%

In the previous week, Encompass Health had 9 more articles in the media than AirSculpt Technologies. MarketBeat recorded 12 mentions for Encompass Health and 3 mentions for AirSculpt Technologies. Encompass Health's average media sentiment score of 1.00 beat AirSculpt Technologies' score of 0.63 indicating that Encompass Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AirSculpt Technologies
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Encompass Health
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

AirSculpt Technologies has a beta of 2.29, suggesting that its stock price is 129% more volatile than the broader market. Comparatively, Encompass Health has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

Encompass Health has higher revenue and earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Encompass Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AirSculpt Technologies$147.68M0.33-$11.67M-$0.13N/A
Encompass Health$6.34B2.04$566.20M$6.4020.63

91.5% of AirSculpt Technologies shares are owned by institutional investors. Comparatively, 97.3% of Encompass Health shares are owned by institutional investors. 44.6% of AirSculpt Technologies shares are owned by company insiders. Comparatively, 1.8% of Encompass Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Encompass Health beats AirSculpt Technologies on 14 of the 17 factors compared between the two stocks.

Get AirSculpt Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIRS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AIRS vs. The Competition

MetricAirSculpt TechnologiesHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$48.37M$9.68B$7.47B$11.44B
Dividend YieldN/A2.54%2.47%4.64%
P/E Ratio-5.0332.6132.8129.51
Price / Sales0.331.907.995.27
Price / Cash41.4022.7620.8521.62
Price / Book0.463.364.383.65
Net Income-$11.67M$329.93M$3.51B$394.00M
7 Day Performance-9.14%-6.70%-6.17%-6.39%
1 Month Performance-47.45%-5.41%-7.05%-8.76%
1 Year Performance-83.76%14.22%-2.50%-8.47%

AirSculpt Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AIRS
AirSculpt Technologies
2.7503 of 5 stars
$0.65
-8.9%
$2.75
+320.3%
-82.4%$48.37M$147.68MN/A363
CCM
Concord Medical Services
0.7846 of 5 stars
$3.54
-5.1%
N/A-14.0%$16.20M$460.51MN/A610
NIVF
NewGenIvf Group
1.666 of 5 stars
$0.28
-30.0%
N/A-100.0%$450K$4.73MN/A87
HCA
HCA Healthcare
3.7895 of 5 stars
$504.27
-0.1%
$480.13
-4.8%
-0.6%$105.47B$75.60B16.71320,000
THC
Tenet Healthcare
3.6302 of 5 stars
$290.16
+0.4%
$293.48
+1.1%
+40.6%$23.00B$21.31B8.4299,000

Related Companies and Tools


This page (NASDAQ:AIRS) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners